Albumin 5% Ophthalmic Solution is for topical ophthalmic use and commonly prescribed as a tear supplement for the treatment of dry eye.
- Volume: 10ml
- Concentration: 5%
- We exclusively compound Albumin 5% Ophthalmic Solution for ophthalmic use only
- Compounded in a sterile compounding facility that is <795>, <797> and <800> chapter compliant
References:
- Shtein RM, Shen JF, Kuo AN, Hammersmith KM, Li JY, Weikert MP. Autologous serum-based eye drops for treatment of ocular surface disease: A report by the American Academy of Ophthalmology. Ophthalmology. 2020;127(1):128–133. PMID: 31561880. https://pubmed.ncbi.nlm.nih.gov/31561880/
- Geerling G, Maclennan S, Hartwig D. Autologous serum eye drops for ocular surface disorders. Br J Ophthalmol. 2004;88(11):1467–1474. PMID: 15489495. https://pubmed.ncbi.nlm.nih.gov/15489495/
- García-Martín E, Pernía-López S, Romero Jiménez RM, García-Valcárcel B, Martínez-Ortega PA, Sanjurjo-Saez M. The use of autologous serum eye drops for the treatment of ocular surface disorders. Eur J Hosp Pharm. 2019 Nov;26(6):314–317. PMID: 31798853. https://pubmed.ncbi.nlm.nih.gov/31798853/
- Quinto GG, Campos M, Behrens A. Autologous serum for ocular surface diseases. Arq Bras Oftalmol. 2008;71(6 Suppl):47–54. PMID: 19274411. https://pubmed.ncbi.nlm.nih.gov/19274411/
- Unterlauft JD, Kohlhaas M, Hofbauer I, Kasper K, Geerling G. Albumin eye drops for treatment of ocular surface diseases [Article in German]. Ophthalmologe. 2009;106(10):932–937. PMID: 19813016. https://pubmed.ncbi.nlm.nih.gov/19813016/
Contact us to inquire about customizations and for detailed pricing information. Please note that all compounds require a valid, patient-specific prescription.